DS

Daljit Singh Chhatwal

Active Director Director DIN 10348721
DIN 10348721 First appointment Oct 2023 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Daljit Singh Chhatwal

Data last updated:

Daljit Singh Chhatwal is a Director at Bhasin Pharmaceuticals Limited (since 2023). The company operates in Pharma.

DIN 10348721
Primary Designation Director
Industry Pharma
First Appointment 10 Oct 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Bhasin Pharmaceuticals Limited U46511HR2023PLC115598
Director10 Oct 20232023Active

Board colleagues of Daljit Singh Chhatwal

Directorship timeline

Open interactive timeline →
Bhasin Pharmaceuticals Limited
Premium access

Shareholding and investment profile for Daljit Singh Chhatwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Daljit Singh Chhatwal

Daljit Singh Chhatwal currently holds 1 directorship: Bhasin Pharmaceuticals Limited (Director, since 10 Oct 2023).

Daljit Singh Chhatwal was first appointed on 10 Oct 2023 as Director at Bhasin Pharmaceuticals Limited.

The current boards of Daljit Singh Chhatwal's companies include Amanjot Singh (Bhasin Pharmaceuticals Limited), Avijeet Singh (Bhasin Pharmaceuticals Limited), Manpreet Singh (Bhasin Pharmaceuticals Limited), Sukhwinder Singh (Bhasin Pharmaceuticals Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available